Select Medical Holdings CORP Stock: price and management transactions · United States · SEC (Form 4)

About Select Medical Holdings CORP

Select Medical Holdings Corporation (NYSE: SEM) is a U.S.-listed healthcare services company headquartered in Mechanicsburg, Pennsylvania, United States. Founded in 1996, the company has built its franchise around specialized post-acute care, rehabilitation, and outpatient therapy services. In recent years, Select Medical has sharpened its strategic focus after the November 2024 separation of Concentra, which removed a non-core asset and left the company more concentrated on its core hospital and rehabilitation platform. For investors, that separation is important because it simplifies the earnings base and makes the underlying operating model easier to analyze. ([selectmedical.com](https://www.selectmedical.com/investor-relations)) Today, Select Medical operates through three main reportable segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation. The critical illness recovery hospitals are designed for patients recovering from severe illnesses and often require complex medical support after discharge from acute-care hospitals. The rehabilitation hospital segment serves patients needing intensive physical rehabilitation, while the outpatient rehabilitation business provides physical, occupational, and speech therapy through a large clinic network. This mix gives the company exposure to several stages of the care continuum and provides multiple reimbursement and referral channels. ([selectmedical.com](https://www.selectmedical.com/-/media/project/selectmedical/inpatients/selectmedical/files/media-and-news/2025-annual-report-10-k.pdf?rev=ee6777fb01be4a488a8d4a03b8dd6569&t=20260219214305)) From a competitive standpoint, Select Medical is one of the major specialized post-acute care providers in the United States, operating in a fragmented market where scale, clinical quality, referral relationships, and geographic density matter. As of March 31, 2026, the company reported 104 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics across 37 states and the District of Columbia. That footprint gives SEM national reach in the U.S. while retaining a specialist operating profile rather than a broad acute-care hospital model. ([selectmedical.com](https://www.selectmedical.com/-/media/project/selectmedical/inpatients/selectmedical/files/earnings-news-releases/select-medical-earnings-release-2026-first-quarter-results.pdf)) Recent headlines have been meaningful for the equity story. Select Medical completed the Concentra spin-off on November 25, 2024, and later disclosed that, on November 24, 2025, Executive Chairman and co-founder Robert A. Ortenzio delivered a non-binding indication of interest to acquire all outstanding shares for cash consideration of $16.00 to $16.20 per share. On the operating side, the company reported first-quarter 2026 revenue of $1.42 billion, up 5.0% year over year, while continuing to pay a cash dividend. For international investors, SEM is therefore a NYSE-listed U.S. healthcare name with a specialist service mix, a sizable national footprint, and a potential strategic transaction overhang that may remain relevant to valuation. ([selectmedical.com](https://www.selectmedical.com/-/media/project/selectmedical/inpatients/selectmedical/files/media-and-news/2025-annual-report-10-k.pdf?rev=ee6777fb01be4a488a8d4a03b8dd6569&t=20260219214305))